Form D · Pharmaceuticals
TesoRx Pharma, LLC
Menlo Park, CA · CIK 0001554258
Offering snapshot reported May 3, 2019 · SEC filing
- Reported sold
- $289K Offering amount: $5.2M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 19, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 3, 2019 | Initial | $289,000 | No comparison | 2 | SEC filing |
| Jul 13, 2016 | Initial | $697,532 | No comparison | 8 | SEC filing |
| May 15, 2014 | Initial | $1,985,000 | No comparison | 3 | SEC filing |
| Jul 30, 2013 | Initial | $3,922,979 | No comparison | 9 | SEC filing |
| Jul 16, 2012 | Initial | $5,922,610 | No comparison | 19 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-338792
Source: Form D, filed May 3, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Guru Betageri | Director |
| Willem A Robberts | Director, Executive |
| Ramachandran Thirucote | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
325 Sharon Park Drive Suite 739
Menlo Park, CA, 94025
Menlo Park, CA, 94025